Report #2833221

Received Mar 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: MD
Recovered: Unknown
Vaccinated: Feb 28, 2025
Onset: Feb 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	UNK	Y011712	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; T/E for VARIVAX on 1/29/2025. HBP reported that vaccines were administered to patients; This spontaneous report was received from regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 29-JAN-2025, a temperature excursion (TE) occurred for Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), at 14.65 degree Fahrenheit (F) for 13 hours and 15 minutes, with no previous TE. On 28-FEB-2025, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection, 0.5 ml, administered as prophylaxis (lot number Y011712 has been verified to be valid for Varicella Virus Vaccine Live [Oka-Merck] [VARIVAX], expiration date 02-Jul-2026) (Product storage error). No additional adverse event was reported for the patient. This is one of several reports from the same reporter.

Other medications

Sterile diluent